177 related articles for article (PubMed ID: 8118816)
1. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
[TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex.
Masuda Y; Kobayashi H; Holland JF; Ohnuma T
Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
5. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y
Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
7. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
8. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
Li Y; Wang Y
Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of human MDR1 mRNA by a hammerhead ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
FEBS Lett; 1993 Mar; 319(1-2):71-4. PubMed ID: 8095909
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes.
Huesker M; Folmer Y; Schneider M; Fulda C; Blum HE; Hafkemeyer P
Hepatology; 2002 Oct; 36(4 Pt 1):874-84. PubMed ID: 12297834
[TBL] [Abstract][Full Text] [Related]
11. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
Dorai T; Kobayashi H; Holland JF; Ohnuma T
Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
[TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
[TBL] [Abstract][Full Text] [Related]
15. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
Kaszubiak A; Holm PS; Lage H
Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
[TBL] [Abstract][Full Text] [Related]
17. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
19. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
Sullivan JM; Pietras KM; Shin BJ; Misasi JN
Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]